Evaluation of plasma von Willebrand factor as a biomarker for acute arterial damage in rats

Toxicologic Pathology

Volumn 28, Issue 5, 2000, Pages 688-693

  Newsholme, S J ^a   Thudium, D T ^a   Gossett, K A ^a   Watson, E S ^a   Schwartz, L W ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Arterial toxicity; Endothelium; Plasma biomarker; Von Willebrand factor

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; FENOLDOPAM; VON WILLEBRAND FACTOR;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BLOOD LEVEL; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG INDUCED DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TOXICITY TESTING; VEIN PUNCTURE;

ANIMALIA;

EID: 0033789298     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800508     Document Type: Article

References (30)

1. Plasma von Willebrand factor and intestinal ischemia-reperfusion injury in rats
2. A reliable marker of endothelial cell dysfunction: Does it exist?
3. Factor-VIII complex and endothelial damage
4. Elevated plasma von Willebrand factor (vWF) levels as an index of acute endothelial injury: Use of a hypotonic injury model in rats
5. Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator
6. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells
7. Characterizaton of the peripheral and central effects of SKandF 82526, a novel dopamine receptor agonist
8. Release of von Willebrand factor antigen (vWF:Ag) and eicosanoids during acute injury to the isolated rat lung
9. Pathogenesis of arterial lesions caused by vasoactive compounds in laboratory animals
10. Distribution of von Willebrand factor in capillary endothelial cells of rat lungs with pulmonary fibrosis
11. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat
12. Role of dopamine and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate in the rat
13. Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders?
14. Von Willebrand factor a marker of endothelial damage?
15. Agonist-stimulated release of von Willebrand factor and procoagulant factor VIII in rats with and without risk factors for stroke
16. Von Willebrand factor is an acute phase reactant in man
17. Rise of factor VIII after exercise and adrenaline infusion, measured by immunological and biological techniques
18. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species
19. Injury induces increase of von Willebrand factor in rat endothelial cells
20. Changes in the aortic endothelium and plasma von Willebrand factor levels during the onset and progression of insulin-dependent diabetes in BB rats
21. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole
22. The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor
23. Acute von Willebrand factor secretion from the endothelium in vivo: Assessment through plasma propeptide (vWF:AgII) levels
24. 2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis
25. Cell biology of von Willebrand factor
26. Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator